166 related articles for article (PubMed ID: 7994573)
41. Structure, function and properties of antibody binding sites.
Mian IS; Bradwell AR; Olson AJ
J Mol Biol; 1991 Jan; 217(1):133-51. PubMed ID: 1988675
[TBL] [Abstract][Full Text] [Related]
42. A neutralizing antibody Fab-influenza haemagglutinin complex with an unprecedented 2:1 stoichiometry: characterization and crystallization.
Gigant B; Barbey-Martin C; Bizebard T; Fleury D; Daniels R; Skehel JJ; Knossow M
Acta Crystallogr D Biol Crystallogr; 2000 Aug; 56(Pt 8):1067-9. PubMed ID: 10944356
[TBL] [Abstract][Full Text] [Related]
43. Spot-scan imaging of microcrystals of an influenza neuraminidase-antibody fragment complex.
Bullough PA; Tulloch PA
Ultramicroscopy; 1991 Feb; 35(2):131-43. PubMed ID: 1866839
[TBL] [Abstract][Full Text] [Related]
44. scFv multimers of the anti-neuraminidase antibody NC10: length of the linker between VH and VL domains dictates precisely the transition between diabodies and triabodies.
Atwell JL; Breheney KA; Lawrence LJ; McCoy AJ; Kortt AA; Hudson PJ
Protein Eng; 1999 Jul; 12(7):597-604. PubMed ID: 10436086
[TBL] [Abstract][Full Text] [Related]
45. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.
Bizebard T; Gigant B; Rigolet P; Rasmussen B; Diat O; Bösecke P; Wharton SA; Skehel JJ; Knossow M
Nature; 1995 Jul; 376(6535):92-4. PubMed ID: 7596443
[TBL] [Abstract][Full Text] [Related]
46. Crystal structure of an idiotype-anti-idiotype Fab complex.
Ban N; Escobar C; Garcia R; Hasel K; Day J; Greenwood A; McPherson A
Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1604-8. PubMed ID: 8127852
[TBL] [Abstract][Full Text] [Related]
47. Interactions of protein antigens with antibodies.
Davies DR; Cohen GH
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):7-12. PubMed ID: 8552677
[TBL] [Abstract][Full Text] [Related]
48. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
[TBL] [Abstract][Full Text] [Related]
49. Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase.
Colman PM; Hoyne PA; Lawrence MC
J Virol; 1993 Jun; 67(6):2972-80. PubMed ID: 8497041
[TBL] [Abstract][Full Text] [Related]
50. Structural Analysis of Der p 1-Antibody Complexes and Comparison with Complexes of Proteins or Peptides with Monoclonal Antibodies.
Osinski T; Pomés A; Majorek KA; Glesner J; Offermann LR; Vailes LD; Chapman MD; Minor W; Chruszcz M
J Immunol; 2015 Jul; 195(1):307-16. PubMed ID: 26026055
[TBL] [Abstract][Full Text] [Related]
51. Triabodies: single chain Fv fragments without a linker form trivalent trimers.
Iliades P; Kortt AA; Hudson PJ
FEBS Lett; 1997 Jun; 409(3):437-41. PubMed ID: 9224705
[TBL] [Abstract][Full Text] [Related]
52. Determination of relative binding affinity of influenza virus N9 sialidases with the Fab fragment of monoclonal antibody NC41 using biosensor technology.
Gruen LC; Kortt AA; Nice E
Eur J Biochem; 1993 Oct; 217(1):319-25. PubMed ID: 8223570
[TBL] [Abstract][Full Text] [Related]
53. Three-dimensional structures of the free and the antigen-complexed Fab from monoclonal anti-lysozyme antibody D44.1.
Braden BC; Souchon H; Eiselé JL; Bentley GA; Bhat TN; Navaza J; Poljak RJ
J Mol Biol; 1994 Nov; 243(4):767-81. PubMed ID: 7966295
[TBL] [Abstract][Full Text] [Related]
54. Crystal structure of signal regulatory protein gamma (SIRPγ) in complex with an antibody Fab fragment.
Nettleship JE; Ren J; Scott DJ; Rahman N; Hatherley D; Zhao Y; Stuart DI; Barclay AN; Owens RJ
BMC Struct Biol; 2013 Jul; 13():13. PubMed ID: 23826770
[TBL] [Abstract][Full Text] [Related]
55. Identification of specificity-determining residues in antibodies.
Padlan EA; Abergel C; Tipper JP
FASEB J; 1995 Jan; 9(1):133-9. PubMed ID: 7821752
[TBL] [Abstract][Full Text] [Related]
56. Three antibody molecules can bind simultaneously to each monomer of the tetramer of influenza virus neuraminidase and the trimer of influenza virus hemagglutinin.
Jackson DC; Crabb BS; Poumbourios P; Tulip WR; Laver WG
Arch Virol; 1991; 116(1-4):45-56. PubMed ID: 2001177
[TBL] [Abstract][Full Text] [Related]
57. Crystal structure of a cross-reaction complex between Fab F9.13.7 and guinea fowl lysozyme.
Lescar J; Pellegrini M; Souchon H; Tello D; Poljak RJ; Peterson N; Greene M; Alzari PM
J Biol Chem; 1995 Jul; 270(30):18067-76. PubMed ID: 7629116
[TBL] [Abstract][Full Text] [Related]
58. Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals.
Desheva Y; Sychev I; Smolonogina T; Rekstin A; Ilyushina N; Lugovtsev V; Samsonova A; Go A; Lerner A
PLoS One; 2018; 13(5):e0196771. PubMed ID: 29742168
[TBL] [Abstract][Full Text] [Related]
59. Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.
Smith TJ; Chase ES; Schmidt TJ; Olson NH; Baker TS
Nature; 1996 Sep; 383(6598):350-4. PubMed ID: 8848050
[TBL] [Abstract][Full Text] [Related]
60. High resolution structures of the 4-4-20 Fab-fluorescein complex in two solvent systems: effects of solvent on structure and antigen-binding affinity.
Herron JN; Terry AH; Johnston S; He XM; Guddat LW; Voss EW; Edmundson AB
Biophys J; 1994 Dec; 67(6):2167-83. PubMed ID: 7696460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
